Guiding ATMPs to patients
Here you will find information on what is happening in Sweden in development of medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. We welcome your collaboration towards accelerated and efficacious patient solutions.
What ATMPs are patients receiving? What ATMP manufacture facilities do we have? What specialist treatment clinics are there? Find out this and more on our ATMP map
Subscribe to our mailing list
Subscribe to receive our quarterly newsletter and updates on the next ATMP Sweden conference.
Follow us on LinkedIn!
Work with us!
Join our experts in the science and technology for GMP compliant clinical translation of ATMPs.
Join our experts in the knowledge, processes and competencies for getting ATMPs to patients.
Find world class facilities, collaborators and resources to drive your ATMP development in Sweden.
News
Better skin for a better life for burns survivors
2019-05-23
Sweden drives National and International collaboration to improve quality of life for burns survivors, saved through skin stem cell transplants
Read more
Spring 2019 ATMP Newsletter
2019-05-09
The Conference edition of our Newsletter! Read more about the success that was ATMP Sweden 2019!
Read more
Sweden’s Gene and Cell therapy Industry showcased at ATMP Sweden 2019
2019-04-02
The era of gene and cell therapy treatments is here!
Read moreATMP success stories
Resources
Use our interactive map to find clinics, manufacture facilities and CAMP/Swelife-ATMP partners.
Use this guide to navigate development of your ATMP to Phase I!
What is the difference between a transplant and a cell based ATMP?
Mikael Wiberg and Anna Sandström discuss the potential and challenges for ATMPs (Swedish)
Events
Find courses, training, conferences and more!
Other collaborating national projects
VOG cell is responsible for ensuring Swedish GMP manfacturing facilities function at the highest level and are compliant with current regulations.
AdBIOPRO is developing Continuous Processing of emerging potent therapeutic products such as recombinant viral vector and cell Products.
This Group will be developing a long term strategy for the future of the ATMP field in Sweden. The Project will ensure that all necessary networks and stakeholders are involved.
See all ATMP relevant organisations here